-
First line immunotherapy for liver cancer! Roche tecentriq + Avastin has a strong curative effect, with a total remission rate of 36% and a 45% reduction in the risk of disease progression / death
Time of Update: 2019-09-28
September 28, 2019 / BIOON / - the annual meeting of the European Society of Oncology (ESMO) in 2019 was held in Barcelona, Spain, from September 27 to October 1 At the meeting, Roche, a Swiss pharmac
-
SCI Rep: old trees bloom new flowers! Heart drugs can significantly improve the survival of children with aggressive brain tumors
Time of Update: 2019-07-18
July 18, 2019 / biourn / - researchers at the University of Nottingham found that the use of a heart drug can significantly improve the survival rate of children with ependymoma (a brain tumor) The fi
-
[quick news] on June 13, 2018, the tetravalent influenza vaccine was approved for the first time in China
Time of Update: 2018-06-13
Our reporter learned from the State Drug Administration on June 11 that the tetravalent influenza virus split vaccine was approved for listing in China to prevent the infection of influenza virus in p
-
[week king] we're going to attack the policy of heavyweight, the hot spots in the pharmaceutical industry, and the frontier news of new drug research and development
Time of Update: 2017-11-20
Direct attack on the latest policy: pharmaceutical e-commerce is not allowed to sell prescription drugs and release prescription drug information On November 14, the General Administration issued the
-
The business strategy of patent challenge in American generic drugs (3
Time of Update: 2017-11-14
6、 Challenge the business strategy of patent 1 Challenge blockbuster From the perspective of the process of patent formation, when the patent examiner grants the patent right, he does not know whether
-
The market size of non blood tumor drugs will reach 140.8 billion US dollars
Time of Update: 2016-04-15
Source: Ding Xiangyuan 2016-04-15 according to GBI research, a business intelligence provider, the global market size of non blood tumor treatment drugs will increase from $72.9 billion in 2014 to $14
-
CDE Drug Evaluation Weekly Report (2015.5.10-2015.5.16
Time of Update: 2015-05-18
In the review this week (2015.5.10-2015.5.16), a total of 111 drugs (excluding supplementary application and review, calculated according to the acceptance number, the same below) entered the review p
-
State Council: the total scale of health service industry has reached more than 8 trillion yuan
Time of Update: 2013-10-16
Several opinions on promoting the development of health service industry (hereinafter referred to as "opinions") released by the State Council on the 14th proposed that by 2020, a health service indu
